The HCV Non-Nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function

Tegobuvir (TGV) is a novel non-nucleoside inhibitor (NNI) of HCV RNA replication with demonstrated antiviral activity in patients with genotype 1 chronic HCV infection. The mechanism of action of TGV has not been clearly defined despite the identification of resistance mutations mapping to the NS5B...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Hebner, Christy M., Han, Bin, Brendza, Katherine M., Nash, Michelle, Sulfab, Maisoun, Tian, Yang, Hung, Magdeleine, Fung, Wanchi, Vivian, Randall W., Trenkle, James, Taylor, James, Bjornson, Kyla, Bondy, Steven, Liu, Xiaohong, Link, John, Neyts, Johan, Sakowicz, Roman, Zhong, Weidong, Tang, Hengli, Schmitz, Uli
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2012
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3374789/
https://ncbi.nlm.nih.gov/pubmed/22720059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0039163
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker